ClinTex are proud to announce that the first of our 7 core CTi applications, the Operational Excellence Module (CTi-OEM), has officially launched.

CTi-OEM provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff and is now live and available for pharma.

This is a huge milestone for the CTi project and the result of 3 years of work and dedication from the ClinTex team.

A huge thank you also to the blockchain and cryptocurrency community, without whom none of this would have been possible.

During the ongoing development of the CTi-PDA application, ClinTex will now work with its partners and industry contacts to identify and drive early adopters for the CTi-OEM application and to augment the exposure of the current suite of clinical data analytics to more real world clinical trial data.

What does this mean for Pharma?

The launch of the CTi_OEM app represents the first step in the elimination of clinical data silos, both within a pharma company, and also across organisational boundaries.

ClinTex are very excited to showcase the CTi_OEM app, and demonstrate its real world application to clinical trials. Pharmaceutical companies now have an easy way to assess the operational efficiency of their clinical trials, using the “plug and play” analytics in CTi_OEM, that are based on industry SDTM data standards.

But CTi-OEM is much more than that — it is the beginning of a new way of thinking in data collaboration, allowing pharmaceutical companies to learn from each other and make new medicine development more efficient, while also protecting their intellectual property.

What does this mean for CTi token holders?

The roll-out of the platform applications marks an important turning point in the tokenomics model of CTi.

The CTi staking distribution comes to an end on 30th September, at which time no more CTi can ever be created or minted. Any excess supply in the staking pool will be burned.

Next…

CTi becomes Deflationary

As you are probably aware by now, any commercial use of the CTi platform requires the client to stake large amounts of CTI from the circulating supply, creating an appreciable deflationary pressure. This reducing supply mechanism is expected to have a value-driving effect on the tokens remaining in the supply.

Further to that, as part of the licencing agreement, every time a client’s CTi licence expires, 20% of the staked CTi tokens are automatically burned during withdrawal as part of the smart contract.

In an effort to maintain transparency we have made the staking contract open source and verifiable on etherscan.io (as we do with all of our token smart contracts).

Read More about the CTi token supply model..

Where can we see it in action?

While CTi-OEM is a business to business application for the clinical trial industry, ClinTex have provided a large number of demonstration videos for the public, running through every aspect of the CTi-OEM interface and platform.

You can see the full suite of demo videos here.

The app itself is hosted on the ClinTex industry website here.

Any clinical trial professionals interested in a live demonstration, on-boarding, or working with ClinTex should contact sales@clintex.io.

What is next for ClinTex CTi?

While CTi-OEM is being showcased for potential early adopters involved in clinical trials, ClinTex will now move into the next stage of its development roadmap, focusing on the CTi_PDA app that will use predictive modelling to forecast issues and events before they happen, driving proactive action to maximise efficiency in clinical trials.

Thank you

Once again, we would like to thank the CTi token community for all their support over the last 3 years. Together we have made it possible to bring CTi to the forefront of a new data-driven era in the conduct and management of clinical trials, using blockchain-powered analytics to break down data silos and to speed up medicines delivery to patients with unmet medical need.

About ClinTex

ClinTex are the team behind Clinical Trials Intelligence, a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials.

Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.

Follow Us:

Clinical Trials Intelligence is a data management software solution for the clinical trials industry that leverages distributed ledger technology